NCT05782608View on ClinicalTrials.gov

IV Ibuprofen vs Ketorolac in Post Operative Pain in Colorectal Cancer Surgeries in Obese Patient

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
IbuprofenKetorolacColorectal Cancer
Interventions
DRUG

IV ibuprofen

Group 1 will receive IV ibuprofen 400mg \\ 6 hours the first dose will be administrated immediately post operative.

DRUG

IV ketorolac

Group 2 will receive 20 mg IV ketorolac\\ 6 hours the first dose will be administrated immediately post operative

Trial Locations (1)

11511

Ahmed Mahmoud Ismail Salama, Cairo

All Listed Sponsors
lead

Cairo University

OTHER